INTRODUCTION {#sec1}
============

*Chlamydia trachomatis* is the most commonly reported bacterial sexually transmitted infection (STI) worldwide, with an estimated 131 million new cases in 2012 (Newman *et al.*[@bib21]). *Chlamydia trachomatis* serovars D-K and L1-L3 primarily cause non-invasive genitourinary infections and invasive lymphogranuloma venereum, respectively. Genital *C. trachomatis* infection is found most often in 15 to 24-year-old women and 20 to 29-year-old men. Many patients are asymptomatic (women 70%--90%, men 30%--50%), thus most cases likely remain undiagnosed and unreported (Markle, Conti and Kad [@bib20]). Factors, other than age, that have been associated with genital chlamydial infection include multiple sex partners, intermittent condom use, cervical ectopy, history of other STIs, and low educational status or socioeconomic position (Markle, Conti and Kad [@bib20]; reviewed by Leonard and Borel [@bib19]).

The role and pathogenicity of *C. trachomatis* in the human gastrointestinal (GI) tract are increasingly debated because of proposals to test and treat more women and men who have sex with men (MSM) for *C. trachomatis* detected in anorectal swabs using nucleic acid amplification tests (NAATs) (Dukers-Muijrers *et al.*[@bib9]). Genitourinary *C. trachomatis* primarily infects columnar mucosal epithelial cells in the endocervix in women, the urethra in women and men. It can also infect rectal columnar epithelium in both women and men. A systematic review found that almost 70% of women with genitourinary *C. trachomatis* infection were also positive for rectal *C. trachomatis* by NAAT, but reported anal intercourse was not associated with detection of anorectal *C. trachomatis* (Chandra *et al.*[@bib6]). Positive NAAT results for anorectal *C. trachomatis* could reflect the detection of non-viable chlamydial nucleic acid, rather than infection. The finding is also consistent with the hypothesis that auto-inoculation, transferring *C. trachomatis* between the genital and anorectal mucosa, can maintain infection in women in the absence of direct inoculation through anal intercourse (Rank and Yeruva [@bib25]). Schachter *et al*. ([@bib26], [@bib27]) reported the presence of viable chlamydiae at different anatomical sites in a prospective study of 131 infants born to *C. trachomatis*-infected mothers. Chlamydiae were recovered by culture from the conjunctiva and nasopharynx within the first 3 weeks of life. Unexpectedly, several infants who had been previously repeatedly tested negative at the rectum became positive after 3--5 months after birth, suggesting that indirect routes of inoculation are possible.

Bavoil and colleagues have proposed that, as in animals, *C. trachomatis* is a natural commensal organism in the human GI tract, asymptomatically colonizing one or more sites (Bavoil *et al.*[@bib1]). *Chlamydia muridarum* infection studies in mice indicate that the GI tract, an immunologically protected site, may be a reservoir for genital re-infection (Perry and Hughes [@bib22]; Igietseme, Portis and Perry [@bib15]; Rank and Yeruva [@bib25]), and long-term chlamydial colonization of the murine GI tract has been demonstrated (Yeruva *et al.*[@bib35]; Zhang *et al.*[@bib36]). Moreover, eradication of chlamydial infection by azithromycin treatment in mice was less effective for GI than for genital infection ([@bib34]a).

Although anorectal *C. trachomatis* is commonly diagnosed by NAATs in women and MSM (Van Liere *et al*. [@bib31], [@bib32]; Dukers-Muijrers *et al.*[@bib9]; Chandra *et al.*[@bib6]), the presence of *C. trachomatis* DNA and/or antigen at more proximal GI sites such as ileum, cecum, appendix and colon have yet to be investigated. The objectives of this study were to examine intestinal biopsy samples taken during colonoscopy for the presence of chlamydial DNA and antigen in patients with and without a history of chlamydial infection and to examine factors associated with a history of chlamydial infection.

MATERIALS AND METHODS {#sec2}
=====================

We conducted this study using pathology records and histopathological specimens obtained during colonoscopy from patients with and without documentation of a history of chlamydial infection.

Definitions of cases and controls {#sec2-1}
---------------------------------

We defined a case as a patient with a possible history of chlamydial infection investigated by colonoscopy at the cantonal hospital Winterthur. We searched for the term 'chlamydia' anywhere in the clinical history or in the comments section of histopathology reports, which are stored electronically. The time period analyzed ranged from 1999 to 2013. If a patient had more than one colonoscopy, we used the findings from only one examination. We chose only episodes in which the keyword 'chlamydia' appeared in the histopathology report and if it appeared more than once, we used the most recent information.

The control group consisted of 234 randomly but chronologically (according to numbers of pathology reports) selected patients at the cantonal hospital Winterthur whose histopathology record did not contain the word 'chlamydia'. All these patients underwent colonoscopy in 2013.

We extracted the same information from the records of both cases and controls and coded each variable, as follows: group assignment (case or control), sex (female or male), clinical signs (none or any, such as abdominal pain, diarrhea etc.), biopsy site (ileum, colon, cecum, appendix, rectum) and results of NAATs done as part of this study to detect chlamydial species (positive or negative). Two pathologists reviewed all histopathology reports and categorized diagnoses as the following: no abnormality, polyp(s), neoplasia, infection/inflammation, ischemia/fibrosis, infection/inflammation AND polyp(s)/neoplasia. All polyps were of the hyperplastic type. Neoplasia included benign epithelial (adenoma) and malignant epithelial tumors (carcinoma). Information about prior or current antibiotic treatment was not available from the patient records.

Intestinal biopsy specimens {#sec2-2}
---------------------------

Formalin-fixed and paraffin-embedded (FFPE) tissue blocks from each patient were retrieved from the pathology archive of the cantonal hospital Winterthur. FFPE blocks containing intestinal anatomic localizations such as ileum, colon, cecum, appendix and rectum were chosen for the study. FFPE blocks containing biopsies taken from the esophagus, stomach and duodenum of the same patients were excluded. Pathology reports of hematoxylin and eosin (HE)-stained sections from all patients were retrieved from the database. The cantonal ethical committee of Zurich approved this project with the limitation that only samples dated prior to December 2013 were allowed to be included.

Statistical analysis {#sec2-3}
--------------------

All data were entered in an Excel^®^ spreadsheet and analyzed using Stata (version 15, Stata Corporation, College Station, Texas). We used descriptive statistics to compare demographic, clinical and histopathological characteristics of cases with a history of chlamydia and control patients. Because of the small number of biopsies for some anatomic sites, we considered all biopsies from each patient together and assigned a histopathological diagnosis for each patient. No patient had different abnormal findings at more than one site. We calculated odds ratios (OR, with 95% confidence intervals, CI) to examine the strength of association with a history of chlamydia. Owing to small numbers of observations for several strata, we did not conduct multivariable analysis.

DNA extraction {#sec2-4}
--------------

From each FFPE block, one 20-μm section was cut and deparaffinized in xylene by centrifugation at 13 800× *g* for 5 min. The supernatant containing the xylene was removed, and the sample washed twice in ethanol, centrifuged at 14 800× *g* for 5 min followed by removal of the supernatant. The remaining pellet was lysed with proteinase K (20 mg/ml, Roche Diagnostics, Mannheim, Germany) on a thermomixer at 56°C and 550 rpm overnight. DNA was extracted using the commercial DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer\'s instructions. All extracts were examined with the Nanodrop^®^ 1000 Version 3.7.1 (Thermo Fisher Scientific, Waltham, MA, USA) to determine DNA quantity and quality.

Real-time PCR for *Chlamydiaceae* {#sec2-5}
---------------------------------

We examined all specimens for the presence of DNA by real-time PCR. Extracted DNA was analyzed on an Applied Biosystems 7500 Real-Time PCR System (Thermo Fisher Scientific) based on the 23S rRNA gene *Chlamydiaceae* family-specific real-time PCR as described by Ehricht *et al.* ([@bib10]), with primers Ch23SF (5΄CTGAAACCAGTAGCTTATAAGCGGT3΄), Ch23SR (5΄ACCTCGCCGTTTAACTTAACTCC3΄) and probe Ch23Sp (5΄FAMCTCATCATGCAAAAGGCACGCCGTAMRA3΄), modified according to Blumer *et al.* ([@bib4]) to include an internal positive control (enhanced green fluorescent protein, eGFP) (Hoffmann *et al.*[@bib13]), with primers EGFP1F (5΄GACCACTACCAGCAGAACAC3΄), EGFP10R (3΄CTTGTACAGCTCGTCCATGC5΄) and probe EGFP1HEX (5΄HEXAGCACCCAGTCCGCCCTGAGCABHQ13΄). The protocol by Blumer *et al.* ([@bib4]) was modified as follows: each 25 μl contained 12.5 μl Applied Biosystems TaqMan Fast Universal PCR MasterMix (2×) (Thermo Fisher Scientific), 500 nM of each primer Ch23SF and Ch23SR, 200 nM of probe Ch23Sp, 100 nM of each eGFP primer EGFP 1F and EGFP10R, 50 nM of eGFP probe EGFP1HEX, 0.25 μl eGFP template and 2.5 μl sample template (all primers and probes from Microsynth, Balgach, Switzerland). The products of the *Chlamydiaceae* and egfp PCRs consist of amplicons of 111 and 177 bp, respectively. The fast cycling profile of the instrument was used: initial denaturation at 95°C for 20 s, followed by 45 cycles of denaturation/elongation (95°C, 3 s and 60°C, 30 s). All samples were tested in duplicate and the cycle threshold was set at 0.1 for each run. A mean cycle threshold (Ct value) \<38 was considered positive, and was used to calculate the corresponding chlamydial load as *Chlamydiaceae* 23S rRNA gene copy number per μl (Staub *et al.*[@bib29]). If several serial sections (see below) of the same FFPE block were positive, the sample with the lowest Ct value was used for the copy number calculation. If the amplification of internal control DNA was inhibited, the run was repeated following 1:10 dilution of the sample. A positive control containing a sevenfold dilution series of *C. abortus* DNA and a negative control of water instead of the template DNA were included in each run (Hoffmann *et al.*[@bib14]).

In PCR-positive cases after the initial screen, ten consecutive sections from each FFPE block were prepared alternating between repetition of the PCR analysis (n = 5) and chlamydial antigen detection by immunohistochemistry (IHC; n = 5) as described previously (Thierry *et al.*[@bib30]).

Chlamydial species identification by Arraymate Microarray {#sec2-6}
---------------------------------------------------------

All samples positive by the *Chlamydiaceae* real-time PCR were further investigated using a species-specific 23S rRNA gene Arraymate microarray assay (Alere, Jena, Germany), as established by Borel *et al.* ([@bib3]). The current version carries 34 probes for 11 *Chlamydiaceae* species, three genus-specific probes, four family markers and 15 probes for *Chlamydia*-like organisms. Additionally, there are four internal control DNA probes and an internal staining control (biotin marker) (Hoffmann *et al.*[@bib14]). Each sample, including internal control DNA (Intype IC-DNA, Qiagen Labor, Leipzig, Germany), was amplified and biotin-labeled using a biotinylation PCR, as described by Borel *et al.* ([@bib3]), with 10 min of initialization (96°C) and 40 cycles of 94°C (denaturation), 50°C (annealing) and 72°C (elongation) for 30 s each. Four to 8 microliter of amplification product was loaded on the chip, which was processed according to manufacturer\'s instructions.

*ompA* PCR and sequencing {#sec2-7}
-------------------------

Samples identified as *C. trachomatis* by Arraymate Microarray were further characterized by conducting a PCR targeting a 219-bp sequence of the variable domain VD-1 region of the *C. trachomatis omp*A gene using the primer pair omp-V1-F (5΄-GACTTTGTTTTCGACCGTGTT-3΄) and omp-V1-R (5΄-ACAAATACATCAAACGATCCCA-3΄) as previously described (Jalal *et al.*[@bib16]; Kese *et al.*[@bib18]) using FastStart *Taq* DNA polymerase (Roche, Basel, Switzerland) under a temperature profile of 95°C for 5 min followed by 40 cycles of 95°C for 60 s, 65°C for 60 s and 72°C for 90 s. Amplicons were purified with the QIAquick PCR Purification Kit (Qiagen) and Sanger sequenced by Microsynth.

Chlamydial antigen detection by immunohistochemistry {#sec2-8}
----------------------------------------------------

The presence of chlamydial antigen in paraffin sections was examined on real-time PCR-positive cases using a *Chlamydiaceae* family-specific mouse monoclonal antibody targeting the chlamydial lipopolysaccharide (LPS, Clone ACI-P, Progen, Heidelberg, Germany) (Blumer *et al.*[@bib4]). A detection kit (Dako, Santa Clara, CA, USA) was used according to the manufacturer\'s instructions. After deparaffinization in xylene and rehydration through graded ethanol to water, the antigen retrieval was performed by a 10-min enzyme digestion (Proteinase K, Dako). The endogenous peroxidase activity was inhibited as described above, then slides were incubated for 60 min with the primary antibody diluted 1:200 in antibody diluent (Dako). The incubation with the link antibody and the substrate solution as well as the counterstaining with hematoxylin was performed as described above. For the positive control, intestinal tissue from gnotobiotic piglets experimentally infected with porcine *Chlamydia suis* strain S45 was used (Guscetti *et al.*[@bib12]).

RESULTS {#sec3}
=======

We retrieved a total of 557 FFPE blocks from 266 patients. The majority of the FFPE control group blocks contained colon (n = 206) and, to a lesser extent, ileum (n = 99) and rectum (n = 25). Cecum and appendix were only available in seven and one patients, respectively. FFPE blocks of the case group contained colon (n = 26), ileum (n = 19), rectum (n = 15), appendix (n = 10) and cecum (n = 1). Patients in both groups underwent colonoscopy because of a risk of colon cancer (e.g. family history), for check-ups (e.g. after surgery), or to investigate clinical symptoms or signs (e.g. non-specific abdominal disorders, diarrhea etc.). Amongst 32 patients identified as cases, 27 underwent colonoscopy once, and five had between two to five examinations between 1999 and 2013. From 42 datasets of 32 patients, we examined 91 FFPE samples. In the control group, all patients (n = 234) underwent colonoscopy once in 2013. Compared with the control group, biopsies for cases were more often available from the appendix and rectum (Table [1](#tbl1){ref-type="table"}).

###### 

Description of data, according to study group.

                                                                                         Total         Case          Control                              
  -------------------------------------------------------------------------------------- ------------- ------------- ------------- ---------------------- ---------
  Sex                                                                                                                                                     0.243
   Female                                                                                149           21 (65.6)     128 (54.7)    1                      
   Male                                                                                  117           11 (34.4)     106 (45.3)    0.63 (0.29, 1.38)      
  Age in years, mean (SD)                                                                58.8 (16.9)   38.8 (22.3)   61.6 (14.0)                          \<0.001
   \<60 years                                                                            120           26 (81.3)     94 (40.2)     6.45 (2.47, 16.90)     
   60+ years                                                                             146           6 (18.8)      140 (59.8)    1                      
  Biopsy site[^b^](#tb1fn2){ref-type="table-fn"}^,^[^c^](#tb1fn3){ref-type="table-fn"}                                                                    
   Ileum                                                                                 115           16 (50.0)     99 (42.3)     1.36 (0.65, 2.86)      0.410
   Colon                                                                                 225           19 (59.4)     206 (88.0)    0.20 (0.09, 0.46)      \<0.001
   Cecum                                                                                 8             1 (3.1)       7 (3.0)       1.05 (0.12, 8.83)      0.828
   Appendix                                                                              11            10 (31.3)     1 (0.4)       105.9 (9.25, \>1000)   \<0.001
   Rectum                                                                                40            15 (46.9)     25 (10.7)     7.38 (3.12, 17.4)      \<0.001
  Histological diagnosis                                                                                                                                  \<0.001
   Infection/inflammation                                                                64            24 (75.0)     40 (17.1)     7.08 (2.49, 20.11)     
   Infection+polyps/hyperplasia                                                          13            2 (6.3)       11 (4.7)      2.15 (0.37, 12.49)     
   Polyps/hyperplasia                                                                    35            0 (0.0)       35 (15.0)     na                     
   Neoplasia                                                                             85            0 (0.0)       85 (36.3)     na                     
   Ischemia/fibrosis                                                                     5             1 (3.1)       4 (1.7)       2.95 (0.27, 31.70)     
   No abnormality                                                                        64            5 (15.6)      59 (25.2)     1                      
  Clinical signs                                                                                                                                          \<0.001
   Yes                                                                                   138           32 (100)      106 (45.3)    na                     
   No                                                                                    128           0 (0.0)       128 (54.7)    1                      
  *Chlamydiaceae* detected                                                                                                                                \<0.001
   Yes                                                                                   4             4 (12.5)      0 (0.0)       na                     
   No                                                                                    262           28 (87.5)     234 (100)     1                      

^a^Numbers presented are mean and standard deviation for age.

^b^Total is greater than 276 because patients could have biopsy from more than one site.

^c^Odds ratio calculated separately for each site comparing cases and controls.

Abbreviations: na, not available (odds ratio could not be calculated because of zero count in one cell); SD, standard deviation.

Description of patients {#sec3-1}
-----------------------

Details of patient characteristics, presence of clinical signs and histopathological diagnosis are shown in Table [1](#tbl1){ref-type="table"}.

There were more female patients amongst both cases (21/32) and controls (128/234). The age range of both groups was similar; year of birth ranged from 1924 to 1990 amongst cases and from 1926 to 1984 for controls, but the mean age of cases was lower than that of controls (38.8 versus 61.6 years).

Clinical symptoms or signs were present in all case patients (n = 32) and in 106 of 234 (45.3%) controls. The most frequent histopathological diagnoses, retrieved from the archived pathology reports, were infectious or inflammatory type lesions amongst cases (n = 24) and neoplasia (n = 85) or no abnormality (n = 59) amongst controls. Infection/inflammation was more common amongst cases than controls (OR 7.08, 95% CI 2.49--12.49) (Table [1](#tbl1){ref-type="table"}).

Detection of *Chlamydia* {#sec3-2}
------------------------

The real-time PCR for *Chlamydiaceae* was negative in all samples (n = 464) from 234 control patients.

Real-time PCR for *Chlamydiaceae* was positive in four tissues (appendix: n = 2; colon: n = 1; rectum: n = 1) from 4 of 32 (12.5%, 95% CI 3.5--29.0%) patients with a history of chlamydia (Table [2](#tbl2){ref-type="table"}). Of these, *C. trachomatis* was identified in three patients and *C. abortus* in one patient by Arraymate microarray. Of the three *C. trachomatis*-positive patients, two were female and one was male.

###### 

Characteristics of patients with *Chlamydiaceae* detected.

                    Biopsy available, PCR result (copy number per μl)                                                                                   
  --- -------- ---- --------------------------------------------------- ------------------ ---- ------------------ ----------------- ------------------ ---------------
  1   Female   55   No                                                  No                 No   Yes, +ve (7.8)     No                *C. trachomatis*   --ve
  2   Male     40   Yes, --ve                                           Yes, --ve          No   No                 Yes, +ve (48.2)   *C. trachomatis*   +ve, rectum
  3   Female   81   Yes, --ve                                           Yes, +ve (349.1)   No   No                 No                *C. abortus*       --ve
  4   Female   24   No                                                  No                 No   Yes, +ve (186.2)   No                *C. trachomatis*   +ve, appendix

yr, years; --ve, negative; +ve, positive.

The male *C. trachomatis*-positive patient (patient 2) was also HIV-positive, and the clinical record included positive test results for *C. trachomatis* and *Neisseria gonorrhoeae*. The histopathologic diagnosis was an ulcero-granulative colitis and active proctitis. From the tissues available (ileum, colon, rectum), only the rectum was positive by PCR (48.2 copies per μl) and Arraymate Microarray (positive for *C. trachomatis*). Sequencing of the PCR product in the VD-I region of *omp*A revealed 99% homology to the *C. trachomatis* LGV *ompA*-genotype L2. By IHC, three out of five serial sections of the rectum contained one or two chlamydial inclusions per section in the lamina propria (Fig. [1](#fig1){ref-type="fig"}A). The ileum and colon were negative for *Chlamydiaceae* antigen detection by IHC (Table [2](#tbl2){ref-type="table"}).

![Immunohistochemistry using a *Chlamydiaceae*-family-specific mouse monoclonal antibody targeting the chlamydial lipopolysaccharide (LPS, Clone ACI-P, Progen), AEC/peroxidase method, hematoxylin counterstain. (**A**) Positive immunolabeling of 2 chlamydial inclusions in the epithelium of the rectal mucosa from patient 2 (magnification 400×). (**B**) Positive immunolabeling of a single chlamydial inclusion in the appendix tissue from patient 4 (magnification 400×). Inset: granular appearance of the chlamydial inclusion in B (magnification 1000×, oil immersion).](fty081fig1){#fig1}

The younger female patient (24 years, patient 4) had a clinical history indicative of *Chlamydia*-associated adnexitis. The histological examination of the appendix revealed an acute partially fibrinous serositis. The appendix was positive for *C. trachomatis* by Arraymate, and by IHC four out of five serial sections contained 1 or 2 chlamydial inclusions in the lamina propria (Fig. [1](#fig1){ref-type="fig"}B). The copy number in the PCR-positive appendix was 186.2 per μl and sequencing of the PCR product in the VD-I region of *ompA* revealed 99% homology to the *C. trachomatis ompA*-genotype F.

The older female patient (age 55 years, patient 1) suffered from unclear abdominal pain in the lower right quadrant, which was the reason for undergoing diagnostic laparoscopy and appendectomy. Histological investigation of the appendix revealed a mild, acute, granulocytic mucosal inflammation and local serositis. The available PCR-positive tissue (appendix) was positive for *C. trachomatis* by Arraymate but negative by IHC. The copy number in the PCR-positive appendix was 7.8 per μl and PCR targeting the VD-I region of *ompA* was not successful.

The *C. abortus*-positive patient (female, age 81 years, patient 3) underwent four colonoscopic examinations between 2011 and 2013. The *Chlamydia*-positive PCR result (349.1 copies per μl) was obtained from the colon sample in 2011. The clinical history at that time included bleeding from the anus and colitis ulcerosa as differential diagnosis. Histopathological examination revealed active colitis with cryptitis (inflammation of the colonic crypts) but the colon was negative for *Chlamydiaceae* by IHC. Follow-up examinations (n = 3) included the histopathological examination of the ileum and the colon which remained negative for *Chlamydia* by PCR. Diagnoses were colitis and polyp in 2012, ulcero-granulative colitis with epitheloid granulomas in 2012 and chronic-active colitis with cryptitis in 2013.

DISCUSSION {#sec4}
==========

*Chlamydia trachomatis* is frequently detected in anorectal specimens from women and MSM. A recent hypothesis (Bavoil *et al.*[@bib1]) proposes that chlamydiae, taken up during oral sex practices, survive in and colonize the GI tract, reaching the rectum. Through fecal shedding, repeated contamination of the female lower genital tract might take place, with a possibility of reproductive sequelae in women if elementary bodies reach the endocervix (Bavoil *et al.*[@bib1]). Intestinal colonization by chlamydiae in animal hosts, e.g. birds, pigs and ruminants, resulting in fecal shedding with subsequent fecal-oral transmission, has been well-documented for decades (Bavoil *et al.*[@bib1]). However, anorectal PCR positivity for *C. trachomatis* in human patients is neither proof of active infection of the rectum, nor of colonization of the intestine. In this study, we were interested to assess whether chlamydiae can be detected in intestinal biopsy tissue samples.

Amongst a group of case patients, with pathology records indicating a documented or suspected chlamydial infection (n = 32), *Chlamydia* species were identified in only 12.5%; three patients were positive for *C. trachomatis* and one for *C. abortus*. Most patients in the case group did not have a current *C. trachomatis* infection detected by NAAT. They were identified using the search term 'chlamydia' in the clinical history or in the comments of the histopathology reports. It is probably rare that *Chlamydia*-positive patients undergo a colonoscopy. In contrast to the controls, the case group comprised a higher number of younger patients (mean 38.8) in which inflammatory lesions were diagnosed more frequently. The male *C. trachomatis*-positive patient had proctitis caused by an LGV genotype, which is known to result in colonoscopic investigation for suspected inflammatory bowel disease (de Vries [@bib7]). The most frequent causes for infectious proctitis are STIs acquired through anal intercourse and include the pathogens *N. gonorrhoeae, C. trachomatis* (including LGV), herpes simplex virus and *Treponema pallidum* (de Vries [@bib7]). There are ongoing epidemics of LGV amongst HIV-infected MSM in Switzerland (Kamarashev *et al.*[@bib17]) and elsewhere in Europe (Ward *et al.*[@bib33]; de Vrieze *et al.*[@bib8]; Peuchant *et al.*[@bib23]).

The two female *C. trachomatis*-positive patients had positive results in appendix tissue, the only submitted tissue from these patients. Spread of sexually transmitted *C. trachomatis* from the endocervix to the fallopian tube and then to the appendix and perihepatitis (Fitz-Hugh Curtis syndrome) are well-recognized complications of ascending chlamydial infection in women. In general, the number of appendix or cecum tissue specimens (11/32 cases and 8/234 controls) was too low to draw any conclusions. The cecum had the highest chlamydial load in an experimental study in ducks (Thierry *et al.*[@bib30]) and was the target tissue in the mouse GI tract following oral *C. muridarum* infection (Yeruva *et al.*[@bib35]). Moreover, the cecum remained positive for up to 100 days post infection in the latter study (Yeruva *et al.*[@bib35]).

The finding of *C. abortus* by Arraymate microarray in the colon of one female patient aged over 80 years is surprising. *Chlamydia abortus* is an animal pathogen causing abortion, stillbirth and neonatal losses in sheep and goats, and to a lesser extent, in cattle, but is also known for its zoonotic potential (Essig and Longbottom [@bib11]). Pregnant women are at risk when they come into contact with the pathogen but intestinal carriage of *C. abortus* in humans has not been reported before. Data anonymization for ethical reasons made it impossible to determine whether the patient had any history of contact with ruminants. The patient suffered from colitis, but this finding seemed unlikely to be associated with an intestinal *C. abortus* infection, given that samples from follow-up investigations (n = 4) continuously revealed colitis while remaining *Chlamydia*-negative.

All *Chlamydia*-positive samples contained 23S rRNA gene copy numbers ranging from 7.8 to 349.1 copies per μl, and, where present, revealed only single IHC-positive cells per section in the lamina propria of the appendix or rectum. These findings are indicative of a low-level infection, which would fit with the colonization hypothesis (Bavoil *et al.*[@bib1]), or might be the result of contamination. Asymptomatic intestinal infection after experimental oral *C. psittaci* inoculation in ducks also resulted in the detection of few chlamydial inclusions by IHC (Thierry *et al.*[@bib30]). Comparable to our findings, single chlamydial inclusions were present in the epithelium of the avian cecum and its subepithelial tissue in the absence of histopathological lesions. In this avian study, chlamydial load measured by PCR was highest in the cecum which contrasted with the detection of very few inclusions by IHC. Sensitivity of IHC is much lower than PCR as only inclusions can be detected by IHC rather than individual elementary and reticulate bodies or DNA copies. Direct comparison between IHC and PCR might be difficult if sections have been taken from different levels of the FFPE blocks, although we tried to reduce this limitation in our study by taking alternating consecutive sections for each method. Moreover, PCR on retrospective FFPE material can be critical as preparation and storage of FFPE blocks leads to physical and chemical changes of DNA of the tissue reducing the length of amplifiable PCR fragments (Burach *et al.*[@bib5]). We tried to overcome this drawback by choosing PCR methods targeting DNA fragments smaller than 200 base pairs, and in case of a positive result, investigating serial sections of FFPE tissue. However, the limited length of the amplified 23S rRNA gene fragments will not allow comparative studies and phylogenetic analysis with corresponding *C. trachomatis* sequences on this material. Amplification of a VD-I region of *omp*A was only successful in two positive patients revealing homology to the LGV L2 *ompA*-genotype in the male and to *ompA*-genotype F in one female patient.

In the past, chlamydial infections have been linked to neoplastic diseases such as ocular MALT lymphoma (Ponzoni and Ferreri [@bib24]). Moreover, chlamydial infections in animal hosts such as the pig can induce enteritis and diarrhea (Schautteet and Vanrompay [@bib28]). *Simkania negevensis* infection rate in colonic biopsies was significantly higher in patients with Crohn\'s disease and ulcerative colitis compared to control patients undergoing colonoscopy suggesting that this *Chlamydia*-like bacterium might be involved in the inflammatory processes of chronic bowel diseases (Belluzzi *et al.*[@bib2]). The association of chlamydial infections and neoplastic or intestinal inflammatory processes prompted us to screen intestinal biopsy samples from randomly selected patients subjected to colonoscopy. In the control group (n = 234), we were not able to detect chlamydial DNA in 464 FFPE blocks containing ileum, colon, cecum, appendix or rectum. This could be explained in part by the limitations of this study. The control group were older patients undergoing colonoscopy and was therefore biased towards hyperplastic and neoplastic lesions, rather than younger adults who are at higher risk of sexually transmitted *C. trachomatis* infection. Also, inflammatory processes in the control group were less common. Due to these limitations, we think it would be premature to conclude that *C. trachomatis* in not present in the GI tract of patients without history of chlamydial infection. A larger sample size targeting the younger and sexually active population would be worth investigating in future studies.

Finally, we have to consider that the presence of *C. trachomatis* DNA/antigen in anorectal swabs or intestinal biopsy samples does not prove that a sustained infection with living/replicating bacteria has occurred. Such findings might represent a mere contamination with non-viable organisms, as NAATs cannot determine whether the organism is viable. Isolation studies or the use of other viability assays are impossible for FFPE material. Prospective studies on fresh tissue samples from the GI tract and with concurrent specimens from genitourinary, anorectal and oropharyngeal sites are required to confirm the findings obtained in this study.
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